Case Pres Lab Drug

8/21/2019 Case Pres Lab Drug

1/27

Laboratory

Examination


2/27

HEMATOLOGY REPORT

August 26, 2014 ( After TAHBSO)

TEST RESULT NORMAL ALUE !NTERPRETAT!ON

Hemoglobin 105 120-150 g/L LO"# is due to the blood

loss during surgical procedure (TAHBS! done

Haematocrit 0"## 0"#$-0"%$ LO"& is due to the blood

loss during surgical

procedure (TAHBS! done

'B 11"# 5"0-10"0/L H!GH# ma) be due to the

in*lammator) process

patient+s urinal)sis result

re,ealed presence o*

bacteria and presence o*

in*lammator) right

*allopian tube"

Segmenters 0"2 0"%5-0".5 H!GH# ma) be due to the

presence o* trauma brought

about b) the surgical

procedure (TAHBS! and

the presence o* in*ection

L)mphoc)tes 0"0$ 0"20-0"#5 LO"# due to the maor

surgical procedure

(TAHBS! done

latelet ount Adeuate 150-#0010/L 3ormal


3/27

BLOO$ %HEM!STRY

August 2&, 2014 (Pr'r t TAHBSO)

EAM!NAT!ON RESULT NORMAL ALUE !NTERPRETAT!ON

reatinine $0"4# 5#-10. umol/L 3ormal

Sodium 1##" 1#5-1%5 mmol HYPONATREM!A *

LO"& ma) be because o*

o,erh)dration lo6 salt indiet or inta7e o* other

medications that a**ect

cause the rapid ecretion

o* sodium in the bod)

otassium %"14 #"5-5"1 mmol 3ormal


4/27

HEMATOLOGY REPORT

August 2&, 2014 (Pr'r t TAHBSO)


Hemoglobin 1%0"5 120-150 g/L 3ormal

Haematocrit 0"%2 0"#$-0"%$ 3ormal

'B 1%"1 5"0-10"0/L H!GH# due to bacterial in*ection

Segmenters 0"$$ 0"%5-0".5 H!GH# due to bacterial

in*ections

L)mphoc)tes 0"12 0"20-0"#5 LO"& because o* the presence o*

increased rates o* in*ection

latelet ount Adeuate 150-#0010/L 3ormal


5/27

Defnition o Lab / Procedure

Is a laboratory analysis performed on a blood sample

that is usually extracted from a vein using a needle ora nger prick.

Blood tests are used to determine physiological andbiochemical states, such as diseases, mineral content,drug eectiveness and organ function. They are also

used during drug tests.Purpose / Indication

Used to monitor a patients progress response totreatment

!easures the number of immature "B#s circulating inthe blood

$rovides information about the erythropoetic activityof the bone marro%

Identies the color, si&e, shape and contents of "B#s


6/27

Nursing Responsibility

BEFRE

#lients, families and signicant others must be informedof the estimated time re'uired to perform the test.

(ssess client if arm)s is)are aected by stroke or anyneurological in*ury that has resulted to loss in sensationor if these areas have excessive scarring, s%elling or skin

conditions+valuate clients anxiety level

Teach relaxation techni'ues to the client

+valuate clients anxiety level


+valuate clients level of safety and comfort

$repare the client by ensuring clients understanding andcompliance %ith the preprocedural re'uirements


7/27

D!RIN"

$repare the procedure room

-ather and charge supplies to be used duringthe procedures

Test safety and integrity of e'uipments

ecure proper containers for specimen

collections#F$ER

end specimen or secure it in the laboratory assoon as extraction is done

"estore the cloents prediagnostic level offunctioning

!onitor client for signs of excessive bleeding

/ocument results and procedure done.


8/27

UR!NALYS!S

August 26, 2014

TEST RESULT !NTERPRETAT!ON

olor 8ello6 3ormalTranparanc) SL" Turbid 3ormal

Speci*ic 9ra,it) 1"015 3ormal

h Acidic 3ormal

Albumin Trace :a) be caused b) a nephrological

condition (6hich is not determined

throught the patient+s course in the

6ard!

Sugar 3egati,e 3ormal

'B 2-5 3ormal

;B .5-40 some clumps HEMATUR!A * H!GH# this ma)

be due to the erosions in the

reproducti,e s)stem caused b) the

gro6ing tumor or the underl)ingin*ection/s

Bacteria


9/27

#% Defnition o Lab / Procedure

(n array of tests performed on urine and one

of the most common methods of medicaldiagnosis. ( part of a urinalysis can beperformed by using urine dipsticks, in %hichthe test results can be read as color changes.

B% Purpose / Indication(ssessment of general health screenings to

detect renal and metabolic diseases

/iagnosis of diseases or disorders of the

kidneys or urinary tract!onitoring of patients %ith diabetes

/iagnose endocrine diseases, bladder cancer,osteoporosis and porphyrias.


10/27

&% Nursing Responsibilities

BEFRE

$repare the client by ensuring clientunderstanding and compliance %ith preprocedural re'uirements

#lient, families and signicant others must be

informed of the estimated time re'uired toperform the test

(ssess clients I01

(ssess clients %eight





11/27

D!RIN"

$rovide for privacy

!aintain a relaxing environment(ssess and maintain integrity of e'uipments

needed

Instruct patient on ho% to obtain a 2cleancatch3

#F$ER

end sample specimen or secure in laboratory

ecure results

(ssess patients level of anxiety

/ocument the characteristic and results andprocedure done


12/27

ARTER!AL BLOO$ GAS RESULT

August 2&, 2014 (Pre+Oer-t'.)


H 4"%#0 4"#5-4"%5 3ormal

2 22"1 #5-%5 mnHg AL/ALOS!S# ma) be due to

the h)per,entilation cause b)

decreased o)genation"

2 ."# $0-100 mnHg --

H# 15"0 22-2. m=/L A%!$OS!S# ma) be due to the

increased production o* Hl

acid caused b) stress (e"g pain

aniet)!"

B"= ." > 2 m=/L --

2 Sat" %"5 4-100 LO"# ma) be reduced because

o* pain rapid loss o* blood

cause b) the c)st gro6th or

presence o* in*ection"


13/27

#% Defnition o Lab / Procedure

Is a laboratory analysis performed on a blood samplethat is usually extracted from an artery using aneedle.

This is used to determine the level of oxygen andcarbon dioxide in the blood and the p4 balance in thebody

B% Purpose / IndicationUsed to determine the level of oxygen, carbon dioxide

and p4 level in the body

Used to determine the presence or conditions such as5

Uncontrolled diabetes4emorrhage

/rug 1verdoes

hock


14/27

&% Nursing Responsibility

BEFRE

#lients, families and signicant others must be informed

of the estimated time re'uired to perform the test.

(ssess client if arm)s is)are aected by stroke or anyneurological in*ury that has resulted to loss in sensationor if these areas have excessive scarring, s%elling orskin conditions






$repare the client by ensuring clients understandingand compliance %ith the preprocedural re'uirements


15/27

D!RIN"

$repare the procedure room

-ather and charge supplies to be used during theprocedures

Test safety and integrity of e'uipments

ecure proper containers for specimen collections

#F$ERend specimen or secure it in the laboratory as

soon as extraction is done

"estore the cloents prediagnostic level of

functioning!onitor client for signs of excessive bleeding

/ocument results and procedure done.


16/27

ULTRASOUN$

$'-g.s's

• 3ormal si?ed anter,erted uterus

•Thic7ened endometrium

•

T/ endometrial c)st both o,aries•)stic *ollicle le*t as described

•T/ in*lammator) right *allopian tube probabl) 6ith in*lammator) processes

#% Defnition o Lab / ProcedureIs an imaging procedure used to determine the internal organs of theabdomen, including the liver, gallbladder, spleen, pancreas andkidneys. The blood vessels that lead to some of these organs can alsobe looked %ith the ultrasound. 6ou %ill be lying do%n for theprocedure. ( clear, %aterbased conducting gel is applied to the skin

over the abdomen. This helps %ith the transmission of the sound%aves. ( handheld probe called a transducer is then moved over theabdomen. 6ou may be asked to change position so that the techniciancan examine dierent areas. 6ou may also be asked to hold yourbreath for short periods of time during the examination.


17/27

B% Purpose / Indication

$erformed to evaluate5

7idneys8iver

-allbladder

$ancreas

pleenUterus

9allopian tubes

1varies

(bdominal aorta

Tumors

Used to provide guidance in biopsies


18/27

&% Nursing Responsibility

BEFRE

9or female clients, assess if pregnant(ssess client if arm)s is)are aected by stroke or anyneurological in*ury that has resulted to loss in sensation or ifthese areas have excessive scarring, s%elling or skinconditions

+valuate clients anxiety level Teach relaxation techni'ues to the client

$repare the client by ensuring clients understanding andcompliance %ith the preprocedural re'uirements

!ay let patient take : tablets of /ulcolax on the night prior

to procedure4ave client on ;$1 after midnight or at least < hours beforeexam

(sk patient to not che% gum or smoke prior to the procedure


19/27

$UR!NGrepare the procedure room

9ather and charge supplies to be used during the proceduresTest sa*et) and integrit) o* euipments@rape client accordingl) or according to

institutional protocolATER Secure reuest and results

@ocument results


20/27

Drug 'tudy


21/27

"eneric

Name

$rade

Name

Fre(uency/Ro

ute/'ide

E)ects

&lassifcatio

n/ #ction

Nursing

&onsiderat

ion

Butimirate inecod9orte

Tablet5 (dult := tablets : to =

times a day

yrup5 (dult >

table spoon ?

times a dayide +ects5

occasional or

mild

gastrointestinal

irritation,

diarrhea,

abdominal

fullness,

nausea

#oughuppresants

@(ntitussivesA

$atient %ithhistory f

peptic ulcer.

$regnancy

and

lactation.;ever give

antitussives

in clients

%ith

productive

coughs.


22/27

"eneric Name $rade Name Fre(uency/Rou

te/ 'ide

E)ects

&lassifcation/

#ction

Nursing

&onsideration

• #elebrex • #elecoxib • 1ral, lo%, =

hr

• ide +ects5

4eadache,

di&&iness,

insomnia,

fatigue,

ophthalmolo

gic eects,nausea,

abdominal

pain,

atulence,

-I bleed,

peripheral

edema,anaphylactoi

d,

leukopenia,

pancytopeni

a,

thrombocyto

penia,

decreased

• (nalgesic

and anti

inammator

y activities

related to

inhibition of

the cox :

en&yme,

%hich isactivated in

inammatio

n to cause

the signs

and

symptoms

associated%ith

inammatio

nC does not

aected the

cox >

en&yme,

%hich

rotects the

• ;ame

confusion

has occurred

bet%een

#elebrex

@#elecoxibA,

#elexa

@#italopramA

, Danax@(lpra&olamA

, and

#erebyx

@9osphenytoi

nAC use

caution.


23/27

"eneric Name $rade Name Fre(uency/Route/

'ide E)ecst

&lassifcation/#cti

on

Nursing

&onsideration• !efenamic (cid • $onstan

• $onstel

• 9re'uency5 :EF

mg '


24/27

"eneric Name $rade Name Fre(uency/Route/

'ide E)ects

&lassifcation/#cti

on

Nursing

&onsideration• 9errous ulfate • 9esol

• 9ero-radumet

• 9re'uency5 BI/

@t%ice a dayA

• "oute5 $1 @per

oremA

• ide +ects5!ild, transient

nausea, heart

burn, anorexia,

constipation,

diarrhea

• #lassication5

Iron preparation

• (ction5 +levates

the serum iron

concentration%hich then

helps to form

high)trapped in

the

reticuloendothel

ial cells for

storage and

eventual

conversation to

a usable form of

iron.

• tore all form at

room temp.

• -ive bet%een

meals %) %ater

but may give %)meals if

gastrointestinal

discomfort

occurs.

• Transient

straining of

mucous

membranes and

teeth %ill occur

%) li'uid iron

preparation. To

avoid, place

li'uid on the

back of the

tongue %)

dropper)use

stra%.

• (void

simultaneous

administration

of antacids)

tetracycline.

•

!onitor dailypattern of bo%el

activit and


25/27

"eneric

Name

$rade Name Fre(uency/R

oute/'ide

E)ects

&lassifcation

/ #ction

Nursing

&onsideratio

n• 9urosemide • 9umide

• 9uromide

• 8asix• 8uramide

• 9re'uency

and "oute5

$1 :FGFmg if

needed

IH)I! :F?F

mg in > on

more

divided

doses up to


26/27

"eneric

Name

$rade Name Fre(uency/Route/

'ide E)ects

&lassifcation/

#ction

Nursing

&onsideration/oxycyclin

e

• (doxa

• (po/oxy

@#(;A

• (tridox• /oryx

• /oxy >FF,

/oxy :FF

• Hibramycin

• 1ral Haries

>.E? hr

• IH"apid +nd of

infusion• /entalC

discolouring

and inade'uate

calcication of

primary teeth of

fetusC if used

by pregnant

%omen.

• /ermatologicC

phototoxic

reactions, rash,

exfoliative

dermatitis.• -IC fatty liver,

liver failure,

anorexia,

nausea,

vomiting,

diarrhea,

glossitis,dyshagia,

Bacteriostati

cC Inhibits

protein

synthesis ofsusceptible

bacteria,

causing cell

death.

• 4istoryC (llergy

totetracycline

renal or hepatic

impairment,pregnancy,

lactation.

• $hysicalC kin

status, " and

sounds, -I

function and

liver evaluation,

urinary output

and

concentration,

urinalysis and

BU;, 89Ts,

renal functiontests.


27/27

"eneric Name $rade Name Fre(uency/Ro

ute/'ide

E)ects

&lassifcation

/ #ction

Nursing

&onsideration

!etronida&ole • 9lagyl

• 9lagyl +"

• !etro -el

• !etro 8otion

• !etro IH

• $1rapid>

=hrGhr

• Tropical

=%k%k

>:hr

• Haginal

unkno%n:hr>:hr

• Therapeutic

, (nti

infectives,

antiproto&o

al, anti

ulcer

agents.

• (ssess for

infection @HI

appearance of

%ound,

sputum, urine

and stoolC ;B#A

at beginning of

and throughout

theraphy.

•

1btainspecimens

forculture and

sensitivity

initiating

theraphy rst

dose may be

given receivingresults.

• !onitor

neurologic

status durinh

and after IH

infusions.

• !onitor intake

Case Pres Lab Drug

Documents

Transcript of Case Pres Lab Drug